{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:28:32Z","timestamp":1791836912222,"version":"4.3.4"},"reference-count":158,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"UC"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaci.2019.11.003","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T07:02:21Z","timestamp":1578034941000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":820,"title":["The microbiome and inflammatory bowel disease"],"prefix":"10.1016","volume":"145","author":[{"given":"Kerri L.","family":"Glassner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bincy P.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn M.M.","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.11.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease","volume":"11","author":"Nishida","year":"2018","journal-title":"Clin J Gastroenterol"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2019.11.003_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000328042","article-title":"Programming of host metabolism by the gut microbiota","volume":"58","author":"Backhed","year":"2011","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.jaci.2019.11.003_bib3","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","article-title":"Microbial influences in inflammatory bowel diseases","volume":"134","author":"Sartor","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.embor.7400731","article-title":"The gut flora as a forgotten organ","volume":"7","author":"O'Hara","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jaci.2019.11.003_bib6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.22547","article-title":"Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice","volume":"120","author":"Veltkamp","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/gut.52.1.79","article-title":"Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis","volume":"52","author":"Ohkusa","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/gutjnl-2015-309333","article-title":"Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence","volume":"65","author":"Schaubeck","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.immuni.2018.12.015","article-title":"Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and RORgammat(+) regulatory T cells and exacerbate colitis in mice","volume":"50","author":"Britton","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.11.003_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/1074-7613(95)90086-1","article-title":"T cells in inflammatory bowel disease: protective and pathogenic roles","volume":"3","author":"Powrie","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.11.003_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/1074-7613(94)90045-0","article-title":"Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells","volume":"1","author":"Powrie","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.11.003_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ibd\/izx014","article-title":"Differential susceptibility to T cell-induced colitis in mice: role of the intestinal microbiota","volume":"24","author":"Reinoso Webb","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0140-6736(91)90663-A","article-title":"Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum","volume":"338","author":"Rutgeerts","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2019.11.003_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/gut.26.3.279","article-title":"Role of the faecal stream in the maintenance of Crohn's colitis","volume":"26","author":"Harper","year":"1985","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00054725-199802000-00006","article-title":"The role of the fecal stream in Crohn's disease: an historical and analytic review","volume":"4","author":"Janowitz","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","article-title":"Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum","volume":"114","author":"D'Haens","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00054725-200111000-00004","article-title":"A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis","volume":"7","author":"Shen","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ibd.20608","article-title":"Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study","volume":"15","author":"Thia","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib19","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/ecco-jcc\/jjz047","article-title":"Low-dose metronidazole is associated with a decreased rate of endoscopic recurrence of Crohn's disease after ileal resection: a retrospective cohort study","volume":"13","author":"Glick","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaci.2019.11.003_bib20","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0016-5085(95)90121-3","article-title":"Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection","volume":"108","author":"Rutgeerts","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib21","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1053\/j.gastro.2019.03.017","article-title":"Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases","volume":"156","author":"Cohen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.11.003_bib23","first-page":"8","article-title":"The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1\/Th17 response","author":"Lavoie","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jaci.2019.11.003_bib24","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2019.11.003_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","article-title":"Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases","volume":"21","author":"Ananthakrishnan","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaci.2019.11.003_bib26","article-title":"Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease","author":"Sokol","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41591-018-0308-z","article-title":"Microbial network disturbances in relapsing refractory Crohn's disease","volume":"25","author":"Yilmaz","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.11.003_bib28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/gast.2003.50153","article-title":"CARD15\/NOD2 functions as an antibacterial factor in human intestinal epithelial cells","volume":"124","author":"Hisamatsu","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib29","doi-asserted-by":"crossref","first-page":"15813","DOI":"10.1073\/pnas.0907722106","article-title":"Nod2 is required for the regulation of commensal microbiota in the intestine","volume":"106","author":"Petnicki-Ocwieja","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.11.003_bib30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.1104911","article-title":"Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract","volume":"307","author":"Kobayashi","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.11.003_bib31","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/ecco-jcc\/jjw095","article-title":"Nod2 deficiency leads to a specific and transmissible mucosa-associated microbial dysbiosis which is independent of the mucosal barrier defect","volume":"10","author":"Al Nabhani","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaci.2019.11.003_bib32","first-page":"700","article-title":"NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer","volume":"123","author":"Couturier-Maillard","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.11.003_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.immuni.2014.06.015","article-title":"Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus","volume":"41","author":"Ramanan","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.11.003_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/gast.2002.30294","article-title":"Mucosal flora in inflammatory bowel disease","volume":"122","author":"Swidsinski","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib35","doi-asserted-by":"crossref","first-page":"e1006177","DOI":"10.1371\/journal.ppat.1006177","article-title":"Nod2: the intestinal gate keeper","volume":"13","author":"Al Nabhani","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaci.2019.11.003_bib36","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/gut.2010.216259","article-title":"Nod2 is essential for temporal development of intestinal microbial communities","volume":"60","author":"Rehman","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib37","doi-asserted-by":"crossref","first-page":"e26284","DOI":"10.1371\/journal.pone.0026284","article-title":"Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.11.003_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ibd.21339","article-title":"Disease\u00a0phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases","volume":"17","author":"Frank","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib39","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/gast.2002.35393","article-title":"Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease","volume":"123","author":"Abreu","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib40","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000186173.14696.ea","article-title":"Crohn's disease patients carrying Nod2\/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence","volume":"242","author":"Alvarez-Lobos","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.jaci.2019.11.003_bib41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/gut.52.4.558","article-title":"CARD15\/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease","volume":"52","author":"Helio","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib42","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1126\/science.aal4677","article-title":"Paneth cells secrete lysozyme via secretory autophagy during bacterial infection of the intestine","volume":"357","author":"Bel","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.11.003_bib43","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1126\/science.aad9948","article-title":"Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease","volume":"352","author":"Chu","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.11.003_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ni.1823","article-title":"Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry","volume":"11","author":"Travassos","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2019.11.003_bib45","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3389\/fimmu.2018.01836","article-title":"Human CARD9: a critical molecule of fungal immune surveillance","volume":"9","author":"Drummond","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2019.11.003_bib46","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1221789","article-title":"Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis","volume":"336","author":"Iliev","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.11.003_bib47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature04926","article-title":"Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity","volume":"442","author":"Gross","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.11.003_bib48","doi-asserted-by":"crossref","first-page":"e1004589","DOI":"10.1371\/journal.ppat.1004589","article-title":"Compartment-specific and sequential role of MyD88 and CARD9 in chemokine induction and innate defense during respiratory fungal infection","volume":"11","author":"Jhingran","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaci.2019.11.003_bib49","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/IAI.01089-13","article-title":"Defect of CARD9 leads to impaired accumulation of gamma interferon-producing memory phenotype T cells in lungs and increased susceptibility to pulmonary infection with Cryptococcus neoformans","volume":"82","author":"Yamamoto","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaci.2019.11.003_bib50","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jaci.2014.12.1930","article-title":"Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both","volume":"135","author":"Lanternier","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.11.003_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.gastro.2013.05.047","article-title":"Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice","volume":"145","author":"Sokol","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib52","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.4102","article-title":"CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands","volume":"22","author":"Lamas","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.11.003_bib53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.11.003_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature06880","article-title":"Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor","volume":"453","author":"Quintana","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.11.003_bib55","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ni.2187","article-title":"AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch","volume":"13","author":"Lee","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2019.11.003_bib56","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0016-5085(03)00385-8","article-title":"Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics","volume":"124","author":"Halfvarson","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib57","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2019.11.003_bib58","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41385-018-0128-y","article-title":"Nod2 influences microbial resilience and susceptibility to colitis following antibiotic exposure","volume":"12","author":"Goethel","year":"2019","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2019.11.003_bib59","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1038\/ajg.2010.398","article-title":"Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease","volume":"105","author":"Shaw","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib60","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jpeds.2012.08.037","article-title":"Association between early childhood otitis media and pediatric inflammatory bowel disease: an exploratory population-based analysis","volume":"162","author":"Shaw","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2019.11.003_bib61","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/ajg.2011.304","article-title":"Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis","volume":"106","author":"Shaw","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib62","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/ajg.2014.246","article-title":"Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis","volume":"109","author":"Ungaro","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib63","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn's disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaci.2019.11.003_bib64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.chom.2015.09.008","article-title":"Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease","volume":"18","author":"Lewis","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaci.2019.11.003_bib65","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1053\/j.gastro.2008.05.081","article-title":"Infectious gastroenteritis and risk of developing inflammatory bowel disease","volume":"135","author":"Porter","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib66","doi-asserted-by":"crossref","first-page":"e1005907","DOI":"10.1371\/journal.ppat.1005907","article-title":"Acute infectious gastroenteritis potentiates a Crohn's disease pathobiont to fuel ongoing inflammation in the post-infectious period","volume":"12","author":"Small","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaci.2019.11.003_bib67","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1053\/j.gastro.2006.02.004","article-title":"Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease","volume":"130","author":"Garcia Rodriguez","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib68","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fped.2018.00197","article-title":"The prebiotic and probiotic properties of human milk: implications for infant immune development and pediatric asthma","volume":"6","author":"Moossavi","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2019.11.003_bib69","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fimmu.2015.00415","article-title":"Breast milk and solid food shaping intestinal immunity","volume":"6","author":"Parigi","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2019.11.003_bib70","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4161\/19490976.2014.969984","article-title":"Lessons from mother: long-term impact of antibodies in breast milk on the gut microbiota and intestinal immune system of breastfed offspring","volume":"5","author":"Rogier","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jaci.2019.11.003_bib71","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1203\/01.pdr.0000200805.45593.17","article-title":"Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris","volume":"59","author":"Coppa","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2019.11.003_bib72","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1542\/peds.2008-3256","article-title":"Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy","volume":"126","author":"Duijts","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2019.11.003_bib73","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1503\/cmaj.121189","article-title":"Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months","volume":"185","author":"Azad","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.jaci.2019.11.003_bib74","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/apt.14291","article-title":"Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis","volume":"46","author":"Xu","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaci.2019.11.003_bib75","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.11.003_bib76","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1572-0241.2006.00381.x","article-title":"A population-based case control study of potential risk factors for IBD","volume":"101","author":"Bernstein","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib77","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature","volume":"106","author":"Hou","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","article-title":"Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease","volume":"65","author":"Quevrain","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib79","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12876-016-0555-8","article-title":"Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration","volume":"16","author":"Kuenzig","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib80","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.gastro.2017.05.010","article-title":"Genetic factors interact with tobacco smoke to modify risk for inflammatory bowel disease in humans and mice","volume":"153","author":"Yadav","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib81","first-page":"7","article-title":"Association between cigarette smoking status and composition of gut microbiota: population-based cross-sectional study","author":"Lee","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2019.11.003_bib82","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s40168-018-0531-3","article-title":"Influence of cigarette smoking on the human duodenal mucosa-associated microbiota","volume":"6","author":"Shanahan","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.jaci.2019.11.003_bib83","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/MIB.0000000000000129","article-title":"Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH","volume":"20","author":"Biedermann","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib84","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.14309\/ajg.0000000000000305","article-title":"The gut microbiome in inflammatory bowel disease: lessons learned from other\u00a0immune-mediated inflammatory diseases","volume":"114","author":"Knox","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib85","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.gastro.2016.10.012","article-title":"Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches","volume":"152","author":"Sartor","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib86","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","article-title":"A microbial signature for Crohn's disease","volume":"66","author":"Pascal","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib87","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","article-title":"Dynamics of the human gut microbiome in inflammatory bowel disease","volume":"2","author":"Halfvarson","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jaci.2019.11.003_bib88","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41564-017-0089-z","article-title":"Dynamics of metatranscription in the inflammatory bowel disease gut microbiome","volume":"3","author":"Schirmer","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jaci.2019.11.003_bib89","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1073\/pnas.1904099116","article-title":"Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide","volume":"116","author":"Henke","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.11.003_bib90","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1574-6976.2002.tb00597.x","article-title":"O-antigen structural variation: mechanisms and possible roles in animal\/plant-microbe interactions","volume":"26","author":"Lerouge","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jaci.2019.11.003_bib91","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1099\/mic.0.051599-0","article-title":"Isoprenoid biosynthesis in bacterial pathogens","volume":"158","author":"Heuston","year":"2012","journal-title":"Microbiology"},{"key":"10.1016\/j.jaci.2019.11.003_bib92","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.11.003_bib93","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib94","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.1600165","article-title":"Diet-derived short chain fatty acids stimulate intestinal epithelial cells to induce mucosal tolerogenic dendritic cells","volume":"198","author":"Goverse","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.11.003_bib95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2019.11.003_bib96","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0016-5085(93)91016-B","article-title":"Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis","volume":"104","author":"Roediger","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib97","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1463-1318.2005.00833.x","article-title":"A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch","volume":"7","author":"Smith","year":"2005","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib98","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1128\/JCM.01360-10","article-title":"Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India","volume":"48","author":"Verma","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaci.2019.11.003_bib99","doi-asserted-by":"crossref","first-page":"571","DOI":"10.15252\/emmm.201606987","article-title":"Niacin ameliorates ulcerative colitis via prostaglandin D2-mediated D prostanoid receptor 1 activation","volume":"9","author":"Li","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jaci.2019.11.003_bib100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jaci.2019.11.003_bib101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2013.11.042","article-title":"Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells","volume":"156","author":"An","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2019.11.003_bib102","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4161\/gmic.26680","article-title":"Interaction of microbes with mucus and mucins: recent developments","volume":"5","author":"Naughton","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jaci.2019.11.003_bib103","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.11.003_bib104","first-page":"978","article-title":"Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease","volume":"20","author":"Rajca","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.MIB.0000440815.76627.64","article-title":"The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models","volume":"20","author":"Martin","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib106","doi-asserted-by":"crossref","first-page":"e109146","DOI":"10.1371\/journal.pone.0109146","article-title":"Faecalibacterium prausnitzii inhibits interleukin-17 to ameliorate colorectal colitis in rats","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.11.003_bib107","first-page":"6","article-title":"Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii","author":"Miquel","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.jaci.2019.11.003_bib108","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/ismej.2016.176","article-title":"Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics","volume":"11","author":"Lopez-Siles","year":"2017","journal-title":"ISME J"},{"key":"10.1016\/j.jaci.2019.11.003_bib109","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.chom.2019.01.007","article-title":"Malassezia is associated with Crohn's disease and exacerbates colitis in mouse models","volume":"25","author":"Limon","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaci.2019.11.003_bib110","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","article-title":"Fungal microbiota dysbiosis in IBD","volume":"66","author":"Sokol","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib111","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-specific alterations in the enteric virome in inflammatory bowel disease","volume":"160","author":"Norman","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2019.11.003_bib112","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gutjnl-2018-318131","article-title":"Gut mucosal virome alterations in ulcerative colitis","volume":"68","author":"Zuo","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib113","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/gut.2005.078303","article-title":"Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis","volume":"55","author":"Kuhbacher","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib114","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1053\/j.gastro.2004.09.001","article-title":"Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition","volume":"127","author":"Petrof","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib115","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib116","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1348-0421.2003.tb03368.x","article-title":"The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease","volume":"47","author":"Shiba","year":"2003","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jaci.2019.11.003_bib117","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.gtc.2017.08.003","article-title":"Probiotics in inflammatory bowel disease","volume":"46","author":"Abraham","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaci.2019.11.003_bib118","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0016-5085(03)00171-9","article-title":"Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial","volume":"124","author":"Gionchetti","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib119","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gut.53.1.108","article-title":"Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis","volume":"53","author":"Mimura","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib120","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ibd.20369","article-title":"Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells","volume":"14","author":"Pronio","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib121","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ibd.20816","article-title":"Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study","volume":"15","author":"Huynh","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib122","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib123","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2036.1997.00225.x","article-title":"Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis","volume":"11","author":"Kruis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaci.2019.11.003_bib124","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ajg.2008.118","article-title":"Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis","volume":"104","author":"Miele","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(98)06343-0","article-title":"Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial","volume":"354","author":"Rembacken","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2019.11.003_bib126","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.gtc.2010.08.006","article-title":"Pharmabiotic manipulation of the microbiota in gastrointestinal disorders, from rationale to reality","volume":"39","author":"Shanahan","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaci.2019.11.003_bib127","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cgh.2013.02.021","article-title":"Saccharomyces boulardii does not prevent relapse of Crohn's disease","volume":"11","author":"Bourreille","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2019.11.003_bib128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.MIB.0000175905.00212.2c","article-title":"A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease","volume":"11","author":"Bousvaros","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib129","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00004836-199712000-00021","article-title":"Crohn's disease and Escherichia coli. A\u00a0new approach in therapy to maintain remission of colonic Crohn's disease?","volume":"25","author":"Malchow","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gut.2005.076604","article-title":"Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial","volume":"55","author":"Marteau","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib131","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1007\/s10620-007-0171-0","article-title":"A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease","volume":"53","author":"Rahimi","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.jaci.2019.11.003_bib132","first-page":"CD004826","article-title":"Probiotics for maintenance of remission in Crohn's disease","author":"Rolfe","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2019.11.003_bib133","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-230X-4-5","article-title":"Lactobacillus GG in inducing and maintaining remission of Crohn's disease","volume":"4","author":"Schultz","year":"2004","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib134","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ibd.20063","article-title":"Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection","volume":"13","author":"Van Gossum","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0016-5085(80)90402-3","article-title":"Healing of perineal Crohn's disease with metronidazole","volume":"79","author":"Bernstein","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib136","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5085(82)80332-6","article-title":"Metronidazole therapy for perineal Crohn's disease: a follow-up study","volume":"83","author":"Brandt","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib137","first-page":"533","article-title":"Metronidazole therapy for Crohn's disease and associated fistulae","volume":"79","author":"Jakobovits","year":"1984","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib138","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn's disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib139","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2005.01.010","article-title":"Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Rutgeerts","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.gastro.2016.10.039","article-title":"American Gastroenterological Association Institute technical review on the management of Crohn's disease after surgical resection","volume":"152","author":"Regueiro","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib141","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF00703959","article-title":"Mucosal morphology and faecal bacteriology after ileoanal anastomosis","volume":"6","author":"Santavirta","year":"1991","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib142","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/MIB.0000000000000055","article-title":"Role of intestinal bacteria in the pathogenesis of pouchitis","volume":"20","author":"Batista","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2019.11.003_bib143","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.gastro.2019.04.021","article-title":"Crohn's disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial","volume":"157","author":"Levine","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib144","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2036.2007.03431.x","article-title":"Meta-analysis: enteral nutrition in active Crohn's disease in children","volume":"26","author":"Dziechciarz","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jaci.2019.11.003_bib145","first-page":"CD000542","article-title":"Enteral nutritional therapy for induction of remission in Crohn's disease","author":"Zachos","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2019.11.003_bib146","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","article-title":"ESPEN guideline: clinical nutrition in inflammatory bowel disease","volume":"36","author":"Forbes","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jaci.2019.11.003_bib147","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/gut.51.2.164","article-title":"Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial","volume":"51","author":"Gassull","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2019.11.003_bib148","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/00365529609004877","article-title":"Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis","volume":"31","author":"Messori","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib149","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/014860710202600298","article-title":"Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas","volume":"26","author":"Sakurai","year":"2002","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.jaci.2019.11.003_bib150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1572-0241.2000.01527.x","article-title":"Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial","volume":"95","author":"Verma","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib151","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.gastro.2019.03.015","article-title":"A diet low in red and processed meat does not reduce rate of Crohn's disease flares","volume":"157","author":"Albenberg","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib152","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819836893","article-title":"Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease","volume":"12","author":"Levy","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jaci.2019.11.003_bib153","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2019.11.003_bib154","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib155","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2019.11.003_bib156","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaci.2019.11.003_bib157","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2019.11.003_bib158","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","article-title":"Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis","volume":"156","author":"Paramsothy","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919314861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919314861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:21:47Z","timestamp":1758792107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919314861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0091674919314861"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.11.003","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The microbiome and inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}